Life Sciences Blog

AMA argues that medical reprints should be excluded from Sunshine Act

Posted on October 29th, by Michael Shapiro-Barr

The American Medical Association and others released a letter to the HHS on Monday, arguing that reprints of medical textbooks and journals should be exempt from the Sunshine Act’s reporting requirements.  According to one estimate, medical sales reps distributed about 10 million reprints last year.  The concern is that the final regulations will inadvertently prohibit the distribution of scientifically reviewed information, undermining efforts to improve quality of care.

Read More



Comments are closed.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Media Quotes

  • Mercedes Meyer, a patent lawyer with the firm Drinker Biddle in Washington, D.C., said the Supreme Court’s failure to provide “bright-line guidance”—a ruling that would settle once-and-for all whether patent settlements are legal or not—means there’s “really no difference now than what was going on.” Mercedes Meyer
    CNBC: High Court Allows FTC to Challenge 'Pay-to-Delay' Generics

From the Blog

The Debate Over Mobile Health Software Regulation

On November 19th, the House Energy and Commerce Subcommittee on Health held a hearing to examine the federal regulation of mobile medical applications (mobile...

23 Skidoo – Genomes, Gamesmanship and the First Amendment

On November 22, 2013, the Inquisition collided with the Internet.  On that date, the Food and Drug Administration issued a Warning Letter threatening 23andMe,...

FDA’s Warning Letter to 23andMe: Ethical and Legal Issues

The FDA’s warning letter to 23andMe, the maker of mail-order genetic tests, highlights the challenging legal and ethical issues posed by such products.  While...